PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2026JMIR Aging0 citationsOpen Access

Response Time Dynamics From Noncognitive Ordinal Ecological Momentary Assessment as a Proxy for Symptom Change in Geriatric Depression: Longitudinal Observational Study

View Full Paper
JLJoo Ho LeeJLJee Hang LeeSPSe Hwan Park

Key Result

EMA-adjunctive care responders showed faster response time adaptation than nonresponders (median decay-rate ratio 4.9; 95% credible interval 1.44-14.31).

Study Design

Type

Observational (n=49)

Structured PICO

Do EMA-based response time dynamics predict symptom change in older adults with a history of major depressive disorder undergoing case management?

P
Population
49 community-dwelling adults aged 65 years or older (mean age 70.7, SD 5.8 years; female: 35; male: 14) with a history of major depressive disorder
I
Intervention
Case management incorporating daily Ecological Momentary Assessment (EMA) self-monitoring of mood, appetite, sleep quality, and general well-being over 4 weeks
O
Outcome
Change in depressive symptoms (measured by GDS-15, CESD-R, PHQ-9, BAI) and its association with EMA-based response time dynamicspatient reported

Dynamic characteristics of EMA-based response times can serve as a sensitive digital biomarker for monitoring changes in depressive symptoms in older adults.

Main Result

Effect estimate: median decay-rate ratio 4.9 (95% CI 1.44-14.31)

Abstract

Abstract Background Depressive symptoms in older adults are amplified by social isolation and limited access to clinic-based mental health care. Ecological momentary assessment (EMA) enables remote self-monitoring and unobtrusively captures response times (RTs), which may serve as indicators of psychomotor and cognitive functioning. Objective This study investigated the use of EMA-based RT dynamics for predicting symptom change and profiling potential responders for repeated self-monitoring in late-life depression. Methods Forty-nine community-dwelling adults aged 65 years or older (mean age 70.7, SD 5.8 years; female: 35; male: 14) with a history of major depressive disorder received case management incorporating daily EMA. Participants provided self-reports of mood, appetite, sleep quality, and general well-being. Preassessment and postassessment included the 15-item Short Geriatric Depression Scale (GDS-15), the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), the 9-item Patient Health Questionnaire, and the Beck Anxiety Inventory. RTs were cleaned with an asymmetric IQR rule, z standardized within-person × response level, and modeled with exponential decay curves over successive EMA trials. The efficacy of EMA-adjunctive care was evaluated using pre-post comparisons of symptom scales. We then examined associations between RT-derived features and symptom change using correlational analyses. Finally, Bayesian multilevel modeling was applied to assess the clinical relevance of RT dynamics, including group differences in adaptation patterns. Results Older adults at risk for depression showed significant symptom reductions over the 4-week EMA-adjunctive care period across all 4 psychological scales (CESD-R: mean Δ 11.5; rank-biserial r =0.78; GDS-15: mean Δ 2.14, Cohen d =0.76), alongside high EMA adherence (>90%). In correlational analyses, descriptive EMA score metrics and raw RTs showed modest, symptom-specific associations with symptom change (ΔCESD-R: | r |≈0.29; Δ9-item Patient Health Questionnaire: | r |≈0.32; ΔBeck Anxiety Inventory: | r |≈0.35) but were not significantly related to change in geriatric depression (ΔGDS-15: | r |≈0.24). In contrast, exponential-decay model parameters derived from standardized RT were significantly associated with geriatric depressive symptom change (Δ GDS-15), with the strongest effects observed for the feeling item (eg, decay rate θ b : r =−0.398, asymptote θ c : r =−0.321). Bayesian multilevel modeling further indicated that EMA-adjunctive care responders showed faster RT adaptation than nonresponders (median decay-rate ratio≈4.9, 95% credible interval 1.44-14.31), whereas differences in postadaptation RT levels were smaller and uncertain (median postadaptation RT ratio≈1.25, 95% credible interval 0.95-1.58). Sensitivity analyses showed consistent decay-rate effects across alternative specifications. Conclusions Dynamic characteristics of EMA-based RTs emerged as a sensitive proxy for monitoring changes in depressive symptoms among older adults at risk. These findings highlight the potential use of RTs as digital biomarkers derived from brief, low-burden EMA self-monitoring, supporting the development of scalable and personalized mental health interventions for geriatric populations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lee et al. (2026) conducted an observational in Geriatric depression (n=49). Case management incorporating daily Ecological Momentary Assessment (EMA) was evaluated on Response time adaptation (decay-rate ratio) between responders and nonresponders (median decay-rate ratio 4.9, 95% CI 1.44-14.31). EMA-adjunctive care responders showed faster response time adaptation than nonresponders (median decay-rate ratio 4.9; 95% credible interval 1.44-14.31).

synapsesocial.com/papers/6a0ec598950456576347bdebhttps://doi.org/10.2196/83891
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparing Pre-Post Change Across Groups: Guidelines for Choosing between Difference Scores, ANCOVA, and Residual Change Scores2021 · 61 citations
  2. 2A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial2014 · 340 citations
  3. 3Adjusting for baseline: Change or percentage change?1989 · 126 citations
  4. 4Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale2001 · 5,798 citations
  5. 5Role of patient advocacy stakeholders in science-based regulatory policy at the U.S. Food and Drug Administration (FDA)2017 · 2 citations